3 suspended. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Suspended 3 |
| Phase 2 | 1 | Suspended 1 |
Follow Ischemia: new trials by email Literature Review of Ischemia trials Research Report on Ischemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ACI) in the Treatment of Acute Cerebral Infarction Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#), Aspirin Tablet - Cerebral Infarction | Phase 1 | Suspended | Sclnow Biotechnology Co., Ltd. | 40 | 2026-12-31 | 2026-04-23 |
| Human Umbilical Cord Mesenchymal Stem Cell Therapy (19#iSCLife®-CI) for Cerebral Infarction Patients in Convalescent Period. Allogeneic umbilical cord mesenchymal stem cell, Aspirin Enteric-coated Tablets & Atorvastatin Calcium - Cerebral Infarction | Phase 1 / Phase 2 | Suspended | Sclnow Biotechnology Co., Ltd. | 40 | 2026-12-31 | 2026-04-23 |
| Minimizing Reperfusion Injury in Patients With Acute Myocardial Infarction Post conditioning, Usual Care for STEMI - Acute Myocardial Infarction | Phase 1 | Suspended | University of Cincinnati | 30 | 2008-03-01 | 2014-02-03 |
Cerebral Infarction (2) · ST Elevation Myocardial Infarction (1)
Cardiovascular Diseases (3) · Infarction (3) · Necrosis (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Vascular Diseases (3) · Brain Diseases (2) · Brain Infarction (2) · Brain Ischemia (2) · Central Nervous System Diseases (2) · Cerebrovascular Disorders (2) · Nervous System Diseases (2) · Stroke (2) · Heart Diseases (1)
Aspirin (1) · Atorvastatin (1) · Ischemic Postconditioning (1)
Sclnow Biotechnology Co., Ltd. (2) · University of Cincinnati (1)
China (2) · United States (1)
Lei Guo, Dr (1) · Lei Guo, Dr. (1) · Tarek Helmy, MD (1)